ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,615,836 | +6.8% | 145,729 | +20.8% | 0.00% | 0.0% |
| Q2 2023 | $2,450,321 | -61.8% | 120,646 | -65.7% | 0.00% | -60.0% |
| Q1 2023 | $6,419,312 | +86.2% | 351,936 | +111.1% | 0.01% | +150.0% |
| Q4 2022 | $3,446,963 | -51.3% | 166,681 | -38.4% | 0.00% | -50.0% |
| Q3 2022 | $7,081,000 | +51.6% | 270,683 | +46.9% | 0.00% | +33.3% |
| Q2 2022 | $4,670,000 | +210.7% | 184,300 | +287.2% | 0.00% | +200.0% |
| Q1 2022 | $1,503,000 | -65.9% | 47,604 | -56.3% | 0.00% | -50.0% |
| Q4 2021 | $4,407,000 | +11.9% | 108,900 | -3.6% | 0.00% | 0.0% |
| Q3 2021 | $3,940,000 | -12.1% | 112,985 | -30.8% | 0.00% | -33.3% |
| Q2 2021 | $4,483,000 | +36.0% | 163,269 | +39.1% | 0.00% | +50.0% |
| Q1 2021 | $3,296,000 | +439.4% | 117,396 | +399.2% | 0.00% | – |
| Q4 2020 | $611,000 | +373.6% | 23,518 | +211.7% | 0.00% | – |
| Q3 2020 | $129,000 | -80.3% | 7,546 | -71.4% | 0.00% | -100.0% |
| Q2 2020 | $654,000 | +391.7% | 26,421 | +175.0% | 0.00% | – |
| Q1 2020 | $133,000 | +37.1% | 9,609 | +0.3% | 0.00% | – |
| Q4 2019 | $97,000 | +44.8% | 9,585 | +30.3% | 0.00% | – |
| Q3 2019 | $67,000 | -23.9% | 7,354 | -33.4% | 0.00% | – |
| Q2 2019 | $88,000 | -37.6% | 11,043 | -2.1% | 0.00% | – |
| Q1 2019 | $141,000 | +15.6% | 11,275 | -1.1% | 0.00% | – |
| Q4 2018 | $122,000 | +56.4% | 11,395 | +104.5% | 0.00% | – |
| Q3 2018 | $78,000 | +66.0% | 5,571 | +46.1% | 0.00% | – |
| Q2 2018 | $47,000 | +2.2% | 3,814 | +27.1% | 0.00% | – |
| Q1 2018 | $46,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |